Related Experiment Video
Updated: Jun 14, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
GAIN-BRCA: a graph-based AI-net framework for breast cancer subtype classification using multiomics data
Jai Chand Patel1, Sushil Kumar Shakyawar1, Sahil Sethi1
1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, United States.
We developed GAIN-BRCA, a graph-based method integrating multiomic data for improved breast cancer subtype prediction. This approach enhances prognostic accuracy and identifies novel biomarkers for precision therapeutics.
Area of Science:
- Computational biology
- Genomics
- Bioinformatics
Background:
- Accurate breast cancer subtyping is crucial for prognosis and treatment.
- Existing machine learning models often fail to leverage multiomic data effectively.
- Graph-based integration of omics data remains underexplored for capturing biological associations.
Purpose of the Study:
- To develop a novel graph-based method (GAIN-BRCA) for integrating multiomic datasets (mRNA, DNA methylation, miRNA) from breast cancer patients.
- To improve the accuracy of breast cancer subtype prediction by capturing biological context through feature interactions.
- To identify subtype-specific prognostic biomarkers for precision therapeutics.
Main Methods:
- Developed GAIN-BRCA, a graph-based machine learning framework.
- Integrated native features from mRNA, DNA methylation (CpG), and miRNA data.
- Synthesized features from miRNA-mRNA and CpG-mRNA interactions to compute weights, creating a transformed feature vector.
Main Results:
- GAIN-BRCA achieved superior performance with an Area Under the Receiver Operating Characteristic curve (AUROC) of 0.98 and an accuracy of 0.92.
- Outperformed existing methods MOGONET (0.72 accuracy) and moBRCA-net (0.86 accuracy).
- Identified subtype-specific prognostic genes (e.g., KRAS, TOX, MITF, TOB1) and biomarkers using GAIN-BRCA and SHAP analysis.
Conclusions:
- GAIN-BRCA effectively integrates multiomic data for accurate breast cancer subtyping and prognosis.
- The method identifies novel subtype-specific biomarkers, paving the way for precision medicine.
- The GAIN-BRCA code is publicly available for further research and application.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Genomics
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...